Getting Rihanna’s number, Merck’s Big Drug Deal
Good day for unlisted numbers, Bad day for alternative medicines
GOOD DAY FOR: Unlisted numbers, after the entertainment program Extra published the cellphone numbers of singers Rihanna and Chris Brown. The numbers were printed on court documents that the program put up on screen and, apparently, forgot to blur out. (The Inquisitr)
BAD DAY FOR: Alternative medicines, after U.S. pharmaceutical giant Merck agreed to buy rival Schering-Plough for $41.1 billion, making Merck the second-largest U.S. drugmaker, after Pfizer. Earlier this year, Pfizer offered $62 billion for drugmaker Wyeth. “It clearly is a year of mergers for pharmaceutical companies,” said Natixis Securities analyst Philippe Lanone. (Bloomberg)
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
'Arise, Sir Goldenballs': David Beckham plays the long game in quest for knighthood
Talking Point Former footballer set to be knighted in King's birthday honours after years of snubs
-
Quiz of The Week: 31 May – 6 June
Have you been paying attention to The Week's news?
-
The Week Unwrapped: How did Japan become a space superpower?
Podcast Plus, why on earth are Labubu dolls so popular? Will buy-now-pay-later cause a new financial crisis?